Asian ethnicity-related differences in gastric cancer presentation and outcome among patients treated at a Canadian Cancer Center

Journal of Clinical Oncology

Volumn 21, Issue 11, 2003, Pages 2070-2076

  Gill, Sharlene ^a   Shah, Amil ^a   Le, Nhu ^a   Cook, E Francis ^a   Yoshida, Eric M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ASIAN; CANCER CENTER; CANCER LOCALIZATION; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; ETHNICITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PATIENT IDENTIFICATION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REVIEW; STOMACH ADENOCARCINOMA; TREATMENT OUTCOME; ADENOCARCINOMA; ADULT; ARTICLE; ASIA; CANADA; ETHNIC GROUP; ETHNOLOGY; FEMALE; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; RETROSPECTIVE STUDY; SIGNET RING CARCINOMA; STOMACH TUMOR; SURVIVAL RATE;

ADENOCARCINOMA; ADULT; ASIA; BRITISH COLUMBIA; CARCINOMA, SIGNET RING CELL; ETHNIC GROUPS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 0038545199     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.11.054     Document Type: Review

References (52)

1. Parkin DM, Pisani P, Ferlay J: Global cancer statistics. CA Cancer J Clin 49:33-64, 1999
2. National Cancer Institute of Canada: Canadian Cancer Statistics 2001. http://www.cancer.ca
3. Greenlee RT, Hill-Harmon MB, Murray T, et al: Cancer statistics, 2001. CA Cancer J Clin 51:15-36, 2001
4. Wanebo HJ, Kennedy BJ, Chmiel J, et al: Cancer of the stomach: A patient care study by the American College of Surgeons. Ann Surg 218:583-592, 1993
5. Maruyama K, Sasako M, Kinoshita T, et al: Surgical treatment for gastric cancer: The Japanese approach. Semin Oncol 23:360-368, 1996
6. Fuchs CS, Mayer RJ: Gastric carcinoma. N Engl J Med 333:32-41, 1995
7. Mok YJ, Koo BW, Whang CW, et al: Cancer of the stomach: A review of two hospitals in Korea and Japan. World J Surg 17:777-782, 1993
8. Lee WJ, Lee WC, Houng SJ, et al: Survival after resection of gastric cancer and prognostic relevance of systematic lymph node dissection: Twenty years experience in Taiwan. World J Surg 19:707-713, 1995
9. Davis PA, Sano T: The difference in gastric cancer between Japan, USA and Europe: What are the facts? What are the suggestions? Crit Rev Oncol Hematol 40:77-94, 2001
10. Bollschweiler E, Boettcher K, Hoelscher AH, et al: Is the prognosis for Japanese and German patients with gastric cancer really different? Cancer 71:2918-2925, 1993
11. Hundahl SA, Stemmermann GN, Oishi A: Racial factors cannot explain superior Japanese outcomes in stomach cancer. Arch Surg 131:170-175, 1996
12. Theuer CP, Kurosaki T, Ziogas A, et al: Asian patients with gastric carcinoma in the United States exhibit unique clinical features and superior overall and cancer specific survival rates. Cancer 89:1883-1892, 2000
13. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
14. Schoenfeld DA: Sample-size formula for the proportional-hazards regression model. Biometrics 39:499-503, 1983
15. Cox DR: Regression models and life-tables. J R Stat Soc B 34:187-202, 1972
16. Noguchi Y, Yoshikawa T, Tsuburaya A, et al: Is gastric carcinoma different between Japan and the United States? Cancer 89:2237-2246, 2000
17. Devesa SS, Blot WJ, Fraumeni JF Jr: Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83:2049-2053, 1998
18. Blot WJ, Devesa SS, Kneller RW, et al: Rising incidence of adenocarcinoma of the oesophagus and gastric cardia. J Am Med Assoc 265:1287-1289, 1991
19. Ozawa S, Ando N, Kitagawa Y, et al: Does incidence of carcinoma of the oesophagogastric junction increase? Nippon Geka Gakkai Zashi 99:542-546, 1998 (abstr)
20. Okabayashi T, Gotoda T, Kondo H, et al: Early carcinoma of the gastric cardia in Japan. Cancer 89:2555-2559, 2000
21. Hundahl SA, Phillips JL, Menck HR: The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the "different disease" hypothesis. Cancer 88:921-932, 2000
22. Cimerman M, Repse S, Jelenc F, et al: Comparison of Lauren's, Ming's and WHO histological classifications of gastric cancer as a prognostic factor for operated patients. Int Surg 79:27-32, 1994
23. Maehara Y, Sakaguchi Y, Moriguchi S, et al: Signet ring cell carcinoma of the stomach. Cancer 69:1645-1650, 1992
24. Kim JP, Kim SC, Yang HK: Prognostic significance of signet ring cell carcinoma of the stomach. Surg Oncol 3:221-227, 1994
25. Theuer CP, Nastanski F, Brewster WR, et al: Signet ring cell histology is associated with unique clinical features but does not affect gastric cancer survival. Am Surg 65:915-921, 1999
26. Janunger KG, Hafstrom L, Nygren P, et al: A systematic overview of chemotherapy effects in gastric cancer. Acta Oncol 40:309-326, 2001
27. Glimelius B, Ekstrom K, Hoffman K, et al: Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Ann Oncol 8:163-168, 1997
28. Murad AM, Santiago FF, Petroianu A, et al: Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer. Cancer 72:37-41, 1993
29. Pyrhonen S, Kuitunen T, Nyandoto P, et al: Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. Br J Cancer 71:587-591, 1995
30. Scheithauer W, Kornek G, Zeh B, et al: Palliative chemotherapy vs. supportive care in patients with metastatic gastric cancer: A randomized trial. Proceedings of the International Conference on Biology, Prevention and Treatment of GI Malignancy (2): 1995 (abstr 68)
31. Haugstvedt T, Viste A, Eide GE, et al: The survival benefit of resection in patients with advanced stomach cancer: The Norwegian multicenter experience-Norwegian Stomach Cancer Trial. World J Surg 13:617-621, 1989
32. Meijer S, De Bakker OJ, Hoitsma HF: Palliative resection in gastric cancer. J Surg Oncol 23:77-80, 1983
33. Monson JR, Donohue JH, McIlrath DC, et al: Total gastrectomy for advanced cancer: A worthwhile palliative procedure Cancer 68:1863-1868, 1991
34. Akoh JA, Macintyre IM: Improving survival in gastric cancer: Review of 5-year survival rates in English language publications from 1970. Br J Surg 79:293-299, 1992
35. Bonenkamp JJ, Hermans J, Sasako M, et al: Extended lymph-node dissection for gastric cancer: Dutch Gastric Cancer Group. N Engl J Med 340:908-914, 1999
36. Cuschieri A, Weeden S, Fielding J, et al: Patient survival after D1 and D2 resections for gastric cancer: Long- term results of the MRC randomized surgical trial-Surgical Co-operative Group. Br J Cancer 79:1522-1530, 1999
37. Macdonald JS, Smalley SR, Benedetti J, et al: Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345:725-730, 2001
38. British Columbia Cancer Agency: Cancer Management Guidelines/ Gastrointestinal. 2001. http://www.bccancer.bc.ca
39. Schwarz RE, Zagala-Nevarez K: Ethnic survival differences after gastrectomy for gastric cancer are better explained by factors specific for disease location and individual patient comorbidity. Eur J Surg Oncol 28:214-219, 2002
40. Wang J, Thornton JC, Burastero S, et al: Comparisons for body mass index and body fat percent among Puerto Ricans, blacks, whites and Asians living in the New York City area. Obes Res 4:377-384, 1996
41. Deurenberg P, Deurenberg-Yap M, Guricci S: Asians are different from Caucasians and from each other in their body mass index/body fat percent relationship. Obes Rev 3:141-146, 2002
42. Dhar DK, Kubota H, Tachibana M, et al: Body mass index determines the success of lymph node dissection and predicts the outcome of gastric carcinoma patients. Oncology 59:18-23, 2000
43. Inagawa S, Adachi S, Oda T, et al: Effect of fat volume on postoperative complications and survival rate after D2 dissection for gastric cancer. Gastric Cancer 3:141-144, 2000
44. McCulloch PG, Ochiai A, O'Dowd GM, et al: Comparison of the molecular genetics of c-erb-B2 and p53 expression in stomach cancer in Britain and Japan. Cancer 75:920-925, 1995
45. McCulloch P, Taggart T, Ochiai A, et al: c-erbB2 and p53 expression are not associated with stage progression of gastric cancer in Britain or Japan. Eur J Surg Oncol 23:304-309, 1997
46. Theuer CP, Campbell BS, Peel DJ, et al: Microsatellite instability in Japanese vs European American patients with gastric cancer. Arch Surg 137:960-965, 2002
47. dos Santos NR, Seruca R, Constancia M, et al: Microsatellite instability at multiple loci in gastric carcinoma: Clinicopathologic implications and prognosis. Gastroenterology 110:38-44, 1996
48. Coldman AJ, Braun T, Gallagher RP: The classification of ethnic status using name information. J Epidemiol Community Health 42:390-395, 1988
49. Nicoll A, Bassett K, Ulijaszek SJ: What's in a name? Accuracy of using surnames and forenames in ascribing Asian ethnic identity in English populations. J Epidemiol Community Health 40:364-368, 1986
50. Donaldson LJ, Taylor JB: Patterns of Asian and non-Asian morbidity in hospitals. Br Med J (Clin Res Ed) 286:949-951, 1983
51. Miwa H, Go MF, Sato N: H. pylori and gastric cancer: The Asian enigma. Am J Gastroenterol 97:1106-1112, 2002
52. Terry MB, Gaudet MM, Gammon MD: The epidemiology of gastric cancer. Semin Radiat Oncol 12:111-127, 2002